For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried to give an overview and future prospects of pharmaceutical industry based on new indicators. Here we show the trends of very basic research of small molecule drug and bio-medicine by country, patents assignees, using new indicators for identifying patents related with pharmaceutical entities' marketed drugs and pipeline%日本版NIH及其制药企业,政策制定·战略规划需要佐证.为此,本研究尝试基于新的指标体系进行制药行业的现状俯瞰与未来预测.本篇基于连载第四篇导出的用于辨识制药企业在研药物及药物密切相关专利的新指标,按照国别和专利申请人,揭示低分子药物、不同技术类别的生物药的基础研究能力.
展开▼